Development and characterization of nanoparticulate formulation of a water soluble prodrug of dexamethasone by HIP complexation

Journal of Microencapsulation

Volumn 28, Issue 1, 2011, Pages 10-20

  Gaudana, Ripal ^a   Parenky, Ashwin ^a   Vaishya, Ravi ^a   Samanta, Swapan K ^b   Mitra, Ashim K ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b JUBILANT BIOSYS LTD   (India)

Author keywords

Characterization of nanoparticles; Dextran sulphate; HIP complex; Polymeric nanoparticles; Prodrug; Valinevaline dexamethasone

Indexed keywords

DEXAMETHASONE; DEXTRAN SULFATE; NANOPARTICLE; POLYGLACTIN; PRODRUG; UNCLASSIFIED DRUG; VALYLVALINE DEXAMETHASONE; WATER OIL CREAM;

ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; DRUG FORMULATION; DRUG SOLUBILITY; HYDROPHILICITY; HYDROPHOBIC ION PAIRING; NANOENCAPSULATION; PARTICLE SIZE; SURFACE PROPERTY; SUSTAINED RELEASE FORMULATION; ZETA POTENTIAL;

DELAYED-ACTION PREPARATIONS; DEXAMETHASONE; DEXTRAN SULFATE; DIPEPTIDES; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LACTIC ACID; NANOPARTICLES; NANOTECHNOLOGY; POLYGLYCOLIC ACID; PRODRUGS;

EID: 78650440780     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2010.520093     Document Type: Article

References (30)

1. Agarwal S, Boddu SH, Jain R, Samanta S, Pal D, Mitra AK. Peptide prodrugs: Improved oral absorption of lopinavir, a HIV protease inhibitor. Int J Pharm, 2008;359:7-14.
2. Bala I, Hariharan S, Kumar MN. PLGA nanoparticles in drug delivery: The state of the art. Crit Rev Ther Drug Carrier Syst, 2004;21:387-422.
3. Bilati U, Allemann E, Doelker E. Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nano-particles and process-related stability issues. AAPS PharmSciTech, 2005;6:E594-604.
4. Boddu SH, Jwala J, Vaishya R, Earla R, Karla PK, Pal D, Mitra AK. Novel nanoparticulate gel formulations of steroids for the treatment of mac-ular edema. J Ocul Pharmacol Ther, 2010;26:37-48.
5. Chen Y, Siddalingappa B, Chan PH, Benson HA. Development of a chit-osan-based nanoparticle formulation for delivery of a hydrophilic hex-apeptide, dalargin. Biopolymers, 2008a;90:663-70.
6. Chen Y, Wang F, Benson HA. Effect of formulation factors on incorporation of the hydrophilic peptide dalargin into PLGA and mPEG-PLGA nanoparticles. Biopolymers, 2008b;90:644-50.
7. Cohen-Sela E, Chorny M, Koroukhov N, Danenberg HD, Golomb G. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles. J Controlled Release, 2009;133:90-5.
8. Dai WG, Dong LC. Characterization of physiochemical and biological properties of an insulin/lauryl sulfate complex formed by hydrophobic ion pairing. Int J Pharm, 2007;336:58-66.
9. Dalwadi G, Sunderland B. An ion pairing approach to increase the loading of hydrophilic and lipophilic drugs into PEGylated PLGA nanoparticles. Eur J Pharm Biopharm, 2009;71:231-42.
10. Del Pozo-Rodriguez A, Delgado D, Solinis MA, Gascon AR, Pedraz JL. Solid lipid nanoparticles for retinal gene therapy: Transfection and intracellular trafficking in RPE cells. Int J Pharm, 2008;360:177-83.
11. Feng L, De Dille A, Jameson VJ, Smith L, Dernell WS, Manning MC. Improved potency of cisplatin by hydrophobic ion pairing. Canc Chemother Pharmacol, 2004;54:441-8.
12. Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J, 2010;12:348-60.
13. Gaudana R, Jwala J, Boddu SH, Mitra AK. Recent perspectives in ocular drug delivery. Pharm Res, 2009;26:1197-216.
14. Halfter W. Change in embryonic eye size and retinal cell proliferation following intravitreal injection of glycosaminoglycans. Invest Ophthalmol Vis Sci, 2008;49:3289-98.
15. Kansara V, Hao Y, Mitra AK. Dipeptide monoester ganciclovir prodrugs for transscleral drug delivery: Targeting the oligopeptide transporter on rabbit retina. J Ocul Pharmacol Ther, 2007;23:321-34.
16. Kim DH, Martin DC. Sustained release of dexamethasone from hydro-philic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials, 2006;27:3031-7.
17. Kumar PS, Ramakrishna S, Saini TR, Diwan PV. Influence of microencap-sulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles. Pharmazie, 2006;61:613-17.
18. Li Y, Pei Y, Zhang X, Gu Z, Zhou Z, Yuan W, Zhou J, Zhu J, Gao X. PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats. J Controlled Release, 2001;71:203-11.
19. Majumdar S, Nashed YE, Patel K, Jain R, Itahashi M, Neumann DM, Hill JM, Mitra AK. Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: In vitro and in vivo evaluations. J Ocul Pharmacol Ther, 2005;21:463-74.
20. Meyer JD, Manning MC. Hydrophobic ion pairing: Altering the solubility properties of biomolecules. Pharm Res, 1998;15:188-93.
21. Perez C, Sanchez A, Putnam D, Ting D, Langer R, Alonso MJ. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J Controlled Release, 2001;75:211-24.
22. Singh SR, Grossniklaus HE, Kang SJ, Edelhauser HF, Ambati BK, Kompella UB. Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV. Gene Ther, 2009;16:645-59.
23. Sun S, Liang N, Piao H, Yamamoto H, Kawashima Y, Cui F. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: Formulation, characterization and in vivo evaluation. J Microencapsul, 2010; 27:471-8.
24. Talluri RS, Samanta SK, Gaudana R, Mitra AK. Synthesis, metabolism and cellular permeability of enzymatically stable dipeptide prodrugs of acyclovir. Int J Pharm, 2008;361:118-24.
25. Tan ML, Friedhuber AM, Dunstan DE, Choong PF, Dass CR. The performance of doxorubicin encapsulated in chitosan-dextran sulphate microparticles in an osteosarcoma model. Biomaterials, 2010;31: 541-51.
26. Tewes F, Munnier E, Antoon B, Ngaboni Okassa L, Cohen-Jonathan S, Marchais H, Douziech-Eyrolles L, Souce M, Dubois P, Chourpa I. Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm Biopharm, 2007;66:488-92.
27. Woitiski CB, Veiga F, Ribeiro A, Neufeld R. Design for optimization of nanoparticles integrating biomaterials for orally dosed insulin. Eur J Pharm Biopharm, 2009;73:25-33.
28. Yang L, Cui F, Shi K, Cun D, Wang R. Design of high payload PLGA nanoparticles containing melittin/sodium dodecyl sulfate complex by the hydrophobic ion-pairing technique. Drug Dev Ind Pharm, 2009;35:959-68.
29. Yoo HS, Choi HK, Park TG. Protein-fatty acid complex for enhanced loading and stability within biodegradable nanoparticles. J Pharm Sci, 2001;90:194-201.
30. Yuan H, Jiang SP, Du YZ, Miao J, Zhang XG, Hu FQ. Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nano-particles. Colloids Surf B Biointerfaces, 2009;70:248-53.